Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia

被引:32
作者
Marchetti, Matteo [1 ,2 ,3 ]
Barelli, Stefano [1 ,2 ,3 ]
Zermatten, Maxime G. [1 ,2 ,3 ]
Monnin-Respen, Fanny [1 ,2 ,3 ]
Matthey-Guirao, Elena [1 ,2 ,3 ]
Nicolas, Nicole [1 ,2 ,3 ]
Gomez, Francisco [1 ,2 ,3 ]
Goodyer, Matthew [4 ]
Gerschheimer, Christiane [1 ,2 ,3 ]
Alberio, Lorenzo [1 ,2 ,3 ]
机构
[1] Lausanne Univ Hosp CHUV, Div Hematol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Lausanne Univ Hosp CHUV, Cent Hematol Lab, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne UNIL, Lausanne, Switzerland
[4] Hop Valais, ICH, Hematol Serv, Sion, Switzerland
关键词
LATERAL-FLOW IMMUNOASSAY; SINGLE-CENTER EXPERIENCE; PLATELET-ACTIVATION TEST; LABORATORY DIAGNOSIS; INDUCED ANTIBODIES; 4TS SCORE; HIT; FONDAPARINUX; MANAGEMENT; PATIENT;
D O I
10.1182/blood.2019002845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prompt diagnostic evaluation of suspected heparin-induced thrombocytopenia (HIT) is critical for guiding initial patient management. We assessed the performance of 3 immunoassays detecting anti-platelet factor 4 (PF4)/heparin antibodies, derived a diagnostic algorithm with a short analytical turnaround time (TAT), and prospectively validated the algorithm. Plasma samples were analyzed by Zymutest-HIA-IgG, HemosIL-AcuStar-HIT-IgG, and ID-H/PF4-PaGIA in retrospective (n = 221) and prospective (n = 305) derivation cohorts. We calculated likelihood ratios of result intervals and cutoff values with 100% negative (NPV) and positive (PPV) predictive values for a positive gold standard functional assay (heparin-induced platelet activation [HIPA]). A diagnostic algorithm was established based on the Bayesian combination of pretest probability and likelihood ratios of first- and second-line immunoassays. Cutoffs with 100% PPV for positive HIPA were >3.0 U/mL (HemosIL-AcuStar-HIT-IgG) and titer >= 16 (ID-H/PF4-PaGIA); cutoffs with 100% NPV were <0.13 U/mL and <= 1, respectively. During the prospective validation of the derived algorithm (n = 687), HemosIL-AcuStar-HIT-IgG was used as unique testing in 566 (82.4%) of 687 cases (analytical TAT, 30 minutes). In 121 (17.6%) of 687 unresolved cases, ID-H/PF4-PaGIA was used as second-line testing (additional TAT, 30 minutes). The algorithm accurately predicted HIT in 51 (7.4%) of 687 patients and excluded it in 604 (87.9%) of 687 patients, leaving only 20 (2.9%) cases unresolved. We also identified 12 (1.7%) of 687 positive predictions not confirmed by HIPA: 10 patients with probable HIT despite negative HIPA and 2 possible false-positive algorithm predictions. The combination of pretest probability with first- and second-line immunoassays for anti-PF4/heparin antibodies is accurate for ruling in or out HIT in >= 95% of cases within 60 minutes. This diagnostic approach improves initial management of patients with suspected HIT.
引用
收藏
页码:1171 / 1184
页数:14
相关论文
共 60 条
[1]   Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - A European Perspective [J].
Alatri, Adriano ;
Armstrong, Anna-Elina ;
Greinacher, Andreas ;
Koster, Andreas ;
Kozek-Langenecker, Sibylle A. ;
Lance, Marcus D. ;
Link, Andreas ;
Nielsen, Jorn D. ;
Sandset, Per M. ;
Spanjersberg, Alexander J. ;
Spannagl, Michael .
THROMBOSIS RESEARCH, 2012, 129 (04) :426-433
[2]   My patient is thrombocytopenic! Is (s)he? Why? And what shall I do? A practical approach to thrombocytopenia [J].
Alberio, L. .
HAMOSTASEOLOGIE, 2013, 33 (02) :83-+
[3]   Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia [J].
Alberio, L ;
Kimmerle, S ;
Baumann, A ;
Taleghani, BRM ;
Biasiutti, FD ;
Lämmle, B .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (07) :528-536
[5]   Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia [J].
Althaus, Karina ;
Hron, Gregor ;
Strobel, Ulrike ;
Abbate, Rosanna ;
Rogolino, Angela ;
Davidson, Simon ;
Greinacher, Andreas ;
Bakchoul, Tamam .
THROMBOSIS RESEARCH, 2013, 131 (03) :E85-E90
[6]   Heparin-induced thrombocytopenia [J].
Arepally, Gowthami M. .
BLOOD, 2017, 129 (21) :2864-2872
[7]   Assessing the clinical and cost impact of on-demand immunoassay testing for the diagnosis of heparin induced thrombocytopenia [J].
Caton, Sarah ;
O'Brien, Elly ;
Pannelay, Annie Jullien ;
Cook, Robert G. .
THROMBOSIS RESEARCH, 2016, 140 :155-162
[8]   Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems [J].
Chilver-Stainer, L ;
Lämmle, B ;
Alberio, L .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) :276-282
[9]   Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study [J].
Chong, BH ;
Gallus, AS ;
Cade, JF ;
Magnani, H ;
Manoharan, A ;
Oldmeadow, M ;
Arthur, C ;
Rickard, K ;
Gallo, J ;
Lloyd, J ;
Seshadri, P ;
Chesterman, CN .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) :1170-1175
[10]  
Colucci G., 2015, J Transl Sci, V1, P37